Altimmune, Inc. (LON:0A4C)
London flag London · Delayed Price · Currency is GBP · Price in USD
5.39
-0.48 (-8.10%)
At close: Feb 3, 2026

Altimmune Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
425410475671268305
Market Cap Growth
7.22%-13.68%-29.28%150.19%-12.19%1325.44%
Enterprise Value
282300365504122155
Last Close Price
3.945.808.8913.226.8310.63
PS Ratio
28561.2725640.431418.90-11888.9082.3550.95
PB Ratio
3.084.153.114.361.821.85
P/TBV Ratio
3.084.153.114.681.951.96
EV/Sales Ratio
-18760.081090.28-37.3925.91
Debt / Equity Ratio
0.090.010.000.010.010.01
Asset Turnover
000.00-0.020.06
Quick Ratio
16.8312.9016.6910.9910.7318.99
Current Ratio
17.1813.1117.2611.3111.1719.16
Return on Equity (ROE)
-52.62%-59.86%-46.63%-44.07%-45.69%-36.14%
Return on Assets (ROA)
-30.87%-36.85%-25.00%-25.73%-22.86%-16.10%
Return on Capital Employed (ROCE)
-43.90%-80.10%-42.10%-46.20%-42.30%-16.50%
Earnings Yield
-14.69%-18.54%-14.63%-10.48%-26.74%-11.76%
FCF Yield
-11.62%-15.57%-12.55%-7.76%-24.88%-8.28%
Buyback Yield / Dilution
-17.16%-33.35%-13.47%-13.67%-61.03%-95.33%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.